Below are common questions that can help clarify what sets each program apart
Avoid beverages that contain sorbitol, mannitol, and xylitol, or any other artificial sweetener No dairy or any citrus fruit, (no milk or anything with dairy)
Exendin-4 significantly increased insulin level and phosphorylation of insulin receptor substrate 1 (IRS-1) in rat hippocampus, and could not change the status of tau phosphorylation without insulin in HT22 neurons, suggesting that insulin is required in reduction of tau hyperphosphorylation by GLP-1R agonists (154)
Starting at $ 499 / Month GIP + GLP-1 receptor agonist that is FDA-approved for chronice weight management Zepbound Adults with obesity (BMI 30) or overweight (BMI 27 with a related health condition) Start TodayMore Info Potential Weight Loss* Administration methods** Injections Dose frequency*** Weekly Potential side effects Possible side effects may include nausea, vomiting, constipation, diarrhea, indigestion or stomach discomfort, reduced appetite, headache, fatigue, or injection site reactionsespecially when starting or increasing the dose
Wegovy (Oral) Wegovy (semaglutide) pill, a FDA-approved GLP-1 receptor agonist, taken once a day, to help regulate appetite and feelings of fullness
Phase 2 trial data published in the New England Journal of Medicine showed an average of 24.2% body weight reduction at the highest research quantities over 48 weeks
